Clinical-Stage BioTech Drug Stocks Declined 13% In June

Our BioTech Drug Stocks Portfolio was DOWN 13.2% in June. Before proceeding read "Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know" to better understand why psychedelic stocks are in decline.